Domicilium Real Estate Fund III LP
CIK: 0001945896
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ELOX
Eloxx Pharmaceuticals, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Domicilium Real Estate Fund III LP
Domicilium Real Estate Fund III LP (SEC CIK 0001945896) files insider reports with the SEC as 10% Owner of Eloxx Pharmaceuticals, Inc. (ELOX).
Signal8 holds 4 ownership filings by Domicilium Real Estate Fund III LP (2 Form 3, 2 Form 4), filed between May 4, 2026 and Jun 17, 2026. Those filings report 3 transactions, from May 27, 2026 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Domicilium Real Estate Fund III LP's filings is in SOUTHLAKE, TX.
Recent filings by Domicilium Real Estate Fund III LP
Other insiders filing for Eloxx Pharmaceuticals, Inc. (ELOX)
- Germano Geno J, Director
- Webster Stephen W, Director
- Walts Alan Edmund, Director
- Kjellson Nina S, Director
- Aggarwal Sumit, President and CEO
- Rubin Steven D, Director